speb/financial-data huggingface dataset:
IMMR income_statement (quarterly, 2025-07-31) — Interest Expense: 2829000.00
IMMR income_statement (quarterly, 2025-07-31) — Interest Expense Non Operating: 2829000.00
IMMR income_statement (quarterly, 2025-07-31) — Interest Income: 7741000.00
IMMR income_statement (quarterly, 2025-07-31) — Interest Income Non Operating: 7741000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Inventory: 409455000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Invested Capital: 465820000.00
IMMR cash_flow (quarterly, 2025-07-31) — Investing Cash Flow: 9206000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Investmentin Financial Assets: 13876000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Investments And Advances: 13876000.00
IMMR cash_flow (quarterly, 2025-07-31) — Issuance Of Debt: 163300000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Long Term Capital Lease Obligation: 135912000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Long Term Debt: 170000000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Long Term Debt And Capital Lease Obligation: 305912000.00
IMMR cash_flow (quarterly, 2025-07-31) — Long Term Debt Issuance: 163300000.00
IMMR cash_flow (quarterly, 2025-07-31) — Long Term Debt Payments: -96400000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Minority Interest: 250265000.00
IMMR income_statement (quarterly, 2025-07-31) — Minority Interests: 12786000.00
IMMR cash_flow (quarterly, 2025-07-31) — Net Business Purchase And Sale: 0.00
IMMR balance_sheet (quarterly, 2025-07-31) — Net Debt: 79860000.00
IMMR income_statement (quarterly, 2025-07-31) — Net Income: -930000.00
IMMR income_statement (quarterly, 2025-07-31) — Net Income Common Stockholders: -930000.00
IMMR income_statement (quarterly, 2025-07-31) — Net Income Continuous Operations: -13716000.00
IMMR income_statement (quarterly, 2025-07-31) — Net Income From Continuing And Discontinued Operation: -930000.00
IMMR income_statement (quarterly, 2025-07-31) — Net Income From Continuing Operation Net Minority Interest: -930000.00
IMMR cash_flow (quarterly, 2025-07-31) — Net Income From Continuing Operations: -13716000.00
IMMR income_statement (quarterly, 2025-07-31) — Net Income Including Noncontrolling Interests: -13716000.00
IMMR income_statement (quarterly, 2025-07-31) — Net Interest Income: 4912000.00
IMMR cash_flow (quarterly, 2025-07-31) — Net Investment Purchase And Sale: 12942000.00
IMMR cash_flow (quarterly, 2025-07-31) — Net Issuance Payments Of Debt: 66900000.00
IMMR cash_flow (quarterly, 2025-07-31) — Net Long Term Debt Issuance: 66900000.00
IMMR income_statement (quarterly, 2025-07-31) — Net Non Operating Interest Income Expense: 4912000.00
IMMR cash_flow (quarterly, 2025-07-31) — Net Other Financing Charges: -1542000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Net PPE: 253730000.00
IMMR cash_flow (quarterly, 2025-07-31) — Net PPE Purchase And Sale: -3736000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: 136039000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Liabilities: 23484000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Revenue: 8118000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Taxes Liabilities: 15366000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Non Current Prepaid Assets: 6223000.00
IMMR income_statement (quarterly, 2025-07-31) — Normalized EBITDA: -5295000.00
IMMR income_statement (quarterly, 2025-07-31) — Normalized Income: 923440.00
IMMR cash_flow (quarterly, 2025-07-31) — Operating Cash Flow: -61653000.00
IMMR cash_flow (quarterly, 2025-07-31) — Operating Gains Losses: -4056000.00
IMMR income_statement (quarterly, 2025-07-31) — Operating Income: -23459000.00
IMMR income_statement (quarterly, 2025-07-31) — Operating Revenue: 292032000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 32817199.00
IMMR balance_sheet (quarterly, 2025-07-31) — Other Current Assets: 55315000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Other Current Liabilities: 9677000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Other Equity Adjustments: 354000.00
IMMR income_statement (quarterly, 2025-07-31) — Other Income Expense: -2896000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Other Intangible Assets: 90619000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Other Inventories: 8890000.00
IMMR cash_flow (quarterly, 2025-07-31) — Other Non Cash Items: -38000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Other Non Current Assets: 31226000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Other Non Current Liabilities: 28239000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Other Properties: 253730000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Other Short Term Investments: 77351000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Payables: 236540000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Payables And Accrued Expenses: 286047000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Pensionand Other Post Retirement Benefit Plans Current: 490000.00
IMMR income_statement (quarterly, 2025-07-31) — Pretax Income: -21443000.00
IMMR cash_flow (quarterly, 2025-07-31) — Purchase Of Business: 0.00
IMMR cash_flow (quarterly, 2025-07-31) — Purchase Of Investment: -28921000.00
IMMR cash_flow (quarterly, 2025-07-31) — Purchase Of PPE: -3736000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Receivables: 164612000.00
IMMR income_statement (quarterly, 2025-07-31) — Reconciled Cost Of Revenue: 233568000.00
IMMR income_statement (quarterly, 2025-07-31) — Reconciled Depreciation: 10423000.00
IMMR income_statement (quarterly, 2025-07-31) — Rent Expense Supplemental: 7420000.00
IMMR cash_flow (quarterly, 2025-07-31) — Repayment Of Debt: -96400000.00
IMMR income_statement (quarterly, 2025-07-31) — Restructuring And Mergern Acquisition: 2896000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Retained Earnings: 32256000.00
IMMR cash_flow (quarterly, 2025-07-31) — Sale Of Investment: 41863000.00
IMMR cash_flow (quarterly, 2025-07-31) — Sale Of PPE: 0.00
IMMR income_statement (quarterly, 2025-07-31) — Selling General And Administration: 71500000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Share Issued: 49942199.00
IMMR income_statement (quarterly, 2025-07-31) — Special Income Charges: -2896000.00
IMMR cash_flow (quarterly, 2025-07-31) — Stock Based Compensation: 4514000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 295820000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: 136039000.00
IMMR income_statement (quarterly, 2025-07-31) — Tax Effect Of Unusual Items: -1042560.00
IMMR income_statement (quarterly, 2025-07-31) — Tax Provision: -7727000.00
IMMR income_statement (quarterly, 2025-07-31) — Tax Rate For Calcs: 0.36
IMMR balance_sheet (quarterly, 2025-07-31) — Total Assets: 1261709000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 465820000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Total Debt: 352351000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 546085000.00
IMMR income_statement (quarterly, 2025-07-31) — Total Expenses: 315491000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 715624000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 464836000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 357635000.00
IMMR income_statement (quarterly, 2025-07-31) — Total Operating Income As Reported: -26355000.00
IMMR income_statement (quarterly, 2025-07-31) — Total Unusual Items: -2896000.00
IMMR income_statement (quarterly, 2025-07-31) — Total Unusual Items Excluding Goodwill: -2896000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Treasury Shares Number: 17125000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Treasury Stock: 113019000.00
IMMR balance_sheet (quarterly, 2025-07-31) — Working Capital: 438884000.00
IMMR income_statement (quarterly, 2025-10-31) — +Operating Expense: 90718000.00
IMMR income_statement (quarterly, 2025-10-31) — +Total Revenue: 650174000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 345460000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 318552000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Additional Paid In Capital: 377050000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Available For Sale Securities: 3263000.00
IMMR income_statement (quarterly, 2025-10-31) — Basic Average Shares: 32838000.00
IMMR income_statement (quarterly, 2025-10-31) — Basic EPS: 0.37
IMMR cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 105184000.00
IMMR cash_flow (quarterly, 2025-10-31) — Capital Expenditure: -4315000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Capital Lease Obligations: 177082000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Capital Stock: 50000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 126917000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 186675000.00
IMMR cash_flow (quarterly, 2025-10-31) — Cash Dividends Paid: -3009000.00
IMMR cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: -51088000.00
IMMR cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: 26895000.00
IMMR cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: 70635000.00
IMMR cash_flow (quarterly, 2025-10-31) — Change In Inventory: 31855000.00
IMMR cash_flow (quarterly, 2025-10-31) — Change In Other Current Assets: 110000.00
IMMR cash_flow (quarterly, 2025-10-31) — Change In Other Current Liabilities: -356000.00
IMMR cash_flow (quarterly, 2025-10-31) — Change In Other Working Capital: 18528000.00
IMMR cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: 122353000.00
IMMR cash_flow (quarterly, 2025-10-31) — Change In Prepaid Assets: 13568000.00
IMMR cash_flow (quarterly, 2025-10-31) — Change In Receivables: -154005000.00
IMMR cash_flow (quarterly, 2025-10-31) — Change In Working Capital: 32053000.00
IMMR cash_flow (quarterly, 2025-10-31) — Changes In Cash: 46442000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Common Stock: 50000.00
IMMR cash_flow (quarterly, 2025-10-31) — Common Stock Dividend Paid: -3009000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 306936000.00
IMMR income_statement (quarterly, 2025-10-31) — Cost Of Revenue: 515102000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Current Accrued Expenses: 62686000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Current Assets: 934244000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Current Capital Lease Obligation: 43230000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Current Debt And Capital Lease Obligation: 43230000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Current Deferred Liabilities: 34817000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Current Deferred Revenue: 34817000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 495713000.00
IMMR cash_flow (quarterly, 2025-10-31) — Deferred Income Tax: 681000.00
IMMR cash_flow (quarterly, 2025-10-31) — Deferred Tax: 681000.00
IMMR cash_flow (quarterly, 2025-10-31) — Depreciation Amortization Depletion: 10513000.00
IMMR income_statement (quarterly, 2025-10-31) — Depreciation Amortization Depletion Income Statement: 10487000.00
IMMR cash_flow (quarterly, 2025-10-31) — Depreciation And Amortization: 10513000.00
IMMR income_statement (quarterly, 2025-10-31) — Depreciation And Amortization In Income Statement: 10487000.00
IMMR income_statement (quarterly, 2025-10-31) — Diluted Average Shares: 33240000.00
IMMR income_statement (quarterly, 2025-10-31) — Diluted EPS: 0.36
IMMR income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: 11991000.00
IMMR income_statement (quarterly, 2025-10-31) — EBIT: 44601000.00
IMMR income_statement (quarterly, 2025-10-31) — EBITDA: 55114000.00
IMMR cash_flow (quarterly, 2025-10-31) — End Cash Position: 151626000.00
IMMR cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: -51088000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Finished Goods: 329123000.00
IMMR cash_flow (quarterly, 2025-10-31) — Free Cash Flow: 66320000.00
IMMR cash_flow (quarterly, 2025-10-31) — Gain Loss On Investment Securities: -2529000.00
IMMR cash_flow (quarterly, 2025-10-31) — Gain Loss On Sale Of PPE: 219000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: 312000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Goodwill: 69162000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Goodwill And Other Intangible Assets: 158819000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Gross PPE: 243506000.00
IMMR income_statement (quarterly, 2025-10-31) — Gross Profit: 135072000.00
IMMR income_statement (quarterly, 2025-10-31) — Interest Expense: 2969000.00
IMMR income_statement (quarterly, 2025-10-31) — Interest Expense Non Operating: 2969000.00
IMMR income_statement (quarterly, 2025-10-31) — Interest Income: 4543000.00
IMMR income_statement (quarterly, 2025-10-31) — Interest Income Non Operating: 4543000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Inventory: 377600000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Invested Capital: 429436000.00
IMMR cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: 26895000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Investmentin Financial Assets: 3263000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Investments And Advances: 3263000.00
IMMR cash_flow (quarterly, 2025-10-31) — Issuance Of Debt: 185900000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Long Term Capital Lease Obligation: 133852000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Long Term Debt: 122500000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 256352000.00
IMMR cash_flow (quarterly, 2025-10-31) — Long Term Debt Issuance: 185900000.00
IMMR cash_flow (quarterly, 2025-10-31) — Long Term Debt Payments: -233779000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Minority Interest: 266917000.00
IMMR income_statement (quarterly, 2025-10-31) — Minority Interests: -14891000.00
IMMR cash_flow (quarterly, 2025-10-31) — Net Business Purchase And Sale: 0.00
IMMR income_statement (quarterly, 2025-10-31) — Net Income: 11991000.00
IMMR income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: 11991000.00
IMMR income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: 26882000.00
IMMR income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 11991000.00
IMMR income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 11991000.00
IMMR cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: 26882000.00
IMMR income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: 26882000.00
IMMR income_statement (quarterly, 2025-10-31) — Net Interest Income: 1574000.00
IMMR cash_flow (quarterly, 2025-10-31) — Net Investment Purchase And Sale: 31210000.00
IMMR cash_flow (quarterly, 2025-10-31) — Net Issuance Payments Of Debt: -47879000.00
IMMR cash_flow (quarterly, 2025-10-31) — Net Long Term Debt Issuance: -47879000.00
IMMR income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: 1574000.00
IMMR cash_flow (quarterly, 2025-10-31) — Net Other Financing Charges: -200000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Net PPE: 243506000.00
IMMR cash_flow (quarterly, 2025-10-31) — Net PPE Purchase And Sale: -4315000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 148117000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Liabilities: 23455000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Revenue: 7280000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Taxes Liabilities: 16175000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Non Current Prepaid Assets: 6152000.00
IMMR income_statement (quarterly, 2025-10-31) — Normalized EBITDA: 59410000.00
IMMR income_statement (quarterly, 2025-10-31) — Normalized Income: 14766216.00
IMMR cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: 70635000.00
IMMR cash_flow (quarterly, 2025-10-31) — Operating Gains Losses: -2310000.00
IMMR income_statement (quarterly, 2025-10-31) — Operating Income: 44354000.00
IMMR income_statement (quarterly, 2025-10-31) — Operating Revenue: 650174000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 32876610.00
IMMR balance_sheet (quarterly, 2025-10-31) — Other Current Assets: 51417000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Other Current Liabilities: 8779000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Other Equity Adjustments: 312000.00
IMMR income_statement (quarterly, 2025-10-31) — Other Income Expense: -4296000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Other Intangible Assets: 89657000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Other Inventories: 48477000.00
IMMR cash_flow (quarterly, 2025-10-31) — Other Non Cash Items: 56000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Other Non Current Assets: 31111000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Other Non Current Liabilities: 27722000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Other Properties: 243506000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Other Short Term Investments: 59758000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Payables: 345460000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 408146000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Pensionand Other Post Retirement Benefit Plans Current: 741000.00
IMMR income_statement (quarterly, 2025-10-31) — Pretax Income: 41632000.00
IMMR cash_flow (quarterly, 2025-10-31) — Purchase Of Business: 0.00
IMMR cash_flow (quarterly, 2025-10-31) — Purchase Of Investment: 8436000.00
IMMR cash_flow (quarterly, 2025-10-31) — Purchase Of PPE: -4315000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Receivables: 318552000.00
IMMR income_statement (quarterly, 2025-10-31) — Reconciled Cost Of Revenue: 515076000.00
IMMR income_statement (quarterly, 2025-10-31) — Reconciled Depreciation: 10513000.00
IMMR income_statement (quarterly, 2025-10-31) — Rent Expense Supplemental: 25591000.00
IMMR cash_flow (quarterly, 2025-10-31) — Repayment Of Debt: -233779000.00
IMMR income_statement (quarterly, 2025-10-31) — Restructuring And Mergern Acquisition: 4296000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Retained Earnings: 42743000.00
IMMR cash_flow (quarterly, 2025-10-31) — Sale Of Investment: 22774000.00
IMMR cash_flow (quarterly, 2025-10-31) — Sale Of PPE: 0.00
IMMR income_statement (quarterly, 2025-10-31) — Selling General And Administration: 80231000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Share Issued: 50029484.00
IMMR income_statement (quarterly, 2025-10-31) — Special Income Charges: -4296000.00
IMMR cash_flow (quarterly, 2025-10-31) — Stock Based Compensation: 2760000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 306936000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: 148117000.00
IMMR income_statement (quarterly, 2025-10-31) — Tax Effect Of Unusual Items: -1520784.00
IMMR income_statement (quarterly, 2025-10-31) — Tax Provision: 14750000.00
IMMR income_statement (quarterly, 2025-10-31) — Tax Rate For Calcs: 0.35
IMMR balance_sheet (quarterly, 2025-10-31) — Total Assets: 1377095000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 429436000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Total Debt: 299582000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 573853000.00
IMMR income_statement (quarterly, 2025-10-31) — Total Expenses: 605820000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 803242000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 442851000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 307529000.00
IMMR income_statement (quarterly, 2025-10-31) — Total Operating Income As Reported: 40058000.00
IMMR income_statement (quarterly, 2025-10-31) — Total Unusual Items: -4296000.00
IMMR income_statement (quarterly, 2025-10-31) — Total Unusual Items Excluding Goodwill: -4296000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Treasury Shares Number: 17152874.00
IMMR balance_sheet (quarterly, 2025-10-31) — Treasury Stock: 113219000.00
IMMR balance_sheet (quarterly, 2025-10-31) — Working Capital: 438531000.00
IMMR income_statement (quarterly, 2026-01-31) — +Operating Expense: 85807000.00
IMMR income_statement (quarterly, 2026-01-31) — +Total Revenue: 518488000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 319280000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Accounts Receivable: 418755000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Additional Paid In Capital: 378901000.00
IMMR income_statement (quarterly, 2026-01-31) — Basic Average Shares: 32939000.00
IMMR income_statement (quarterly, 2026-01-31) — Basic EPS: -0.31
IMMR cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 151626000.00
IMMR cash_flow (quarterly, 2026-01-31) — Capital Expenditure: -3730000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Capital Lease Obligations: 172370000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Capital Stock: 50000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 129827000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 177921000.00
IMMR cash_flow (quarterly, 2026-01-31) — Cash Dividends Paid: -2517000.00
IMMR cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: 10255000.00
IMMR cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: 9993000.00
IMMR cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: -33762000.00
IMMR cash_flow (quarterly, 2026-01-31) — Change In Inventory: 4513000.00
IMMR cash_flow (quarterly, 2026-01-31) — Change In Other Current Assets: 121000.00
IMMR cash_flow (quarterly, 2026-01-31) — Change In Other Current Liabilities: -2346000.00
IMMR cash_flow (quarterly, 2026-01-31) — Change In Other Working Capital: 23044000.00
IMMR cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: 39608000.00
IMMR cash_flow (quarterly, 2026-01-31) — Change In Prepaid Assets: -8612000.00
IMMR cash_flow (quarterly, 2026-01-31) — Change In Receivables: -100210000.00
IMMR cash_flow (quarterly, 2026-01-31) — Change In Working Capital: -43882000.00
IMMR cash_flow (quarterly, 2026-01-31) — Changes In Cash: -13514000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Common Stock: 50000.00
IMMR cash_flow (quarterly, 2026-01-31) — Common Stock Dividend Paid: -2517000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 295383000.00
IMMR income_statement (quarterly, 2026-01-31) — Cost Of Revenue: 425579000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Current Accrued Expenses: 126857000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Current Assets: 1013381000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Current Capital Lease Obligation: 39981000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Current Debt And Capital Lease Obligation: 39981000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Current Deferred Liabilities: 55862000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Current Deferred Revenue: 55862000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 553974000.00
IMMR cash_flow (quarterly, 2026-01-31) — Deferred Income Tax: 418000.00
IMMR cash_flow (quarterly, 2026-01-31) — Deferred Tax: 418000.00
IMMR cash_flow (quarterly, 2026-01-31) — Depreciation Amortization Depletion: 10701000.00
IMMR income_statement (quarterly, 2026-01-31) — Depreciation Amortization Depletion Income Statement: 10676000.00
IMMR cash_flow (quarterly, 2026-01-31) — Depreciation And Amortization: 10701000.00
IMMR income_statement (quarterly, 2026-01-31) — Depreciation And Amortization In Income Statement: 10676000.00
IMMR income_statement (quarterly, 2026-01-31) — Diluted Average Shares: 32939000.00
IMMR income_statement (quarterly, 2026-01-31) — Diluted EPS: -0.31
IMMR income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: -10266000.00
IMMR income_statement (quarterly, 2026-01-31) — EBIT: 4985000.00
IMMR income_statement (quarterly, 2026-01-31) — EBITDA: 15686000.00
IMMR cash_flow (quarterly, 2026-01-31) — End Cash Position: 138112000.00
IMMR cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: 10255000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Finished Goods: 329425000.00
IMMR cash_flow (quarterly, 2026-01-31) — Free Cash Flow: -37492000.00
IMMR cash_flow (quarterly, 2026-01-31) — Gain Loss On Investment Securities: 6005000.00
IMMR cash_flow (quarterly, 2026-01-31) — Gain Loss On Sale Of PPE: 62000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Gains Losses Not Affecting Retained Earnings: 122000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Goodwill: 69162000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Goodwill And Other Intangible Assets: 157857000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Gross PPE: 228882000.00
IMMR income_statement (quarterly, 2026-01-31) — Gross Profit: 92909000.00
IMMR income_statement (quarterly, 2026-01-31) — Impairment Of Capital Assets: 1018000.00
IMMR income_statement (quarterly, 2026-01-31) — Interest Expense: 8403000.00
IMMR income_statement (quarterly, 2026-01-31) — Interest Expense Non Operating: 8403000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Inventory: 373087000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Invested Capital: 433783000.00
IMMR cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: 9993000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Investmentin Financial Assets: 0.00
IMMR balance_sheet (quarterly, 2026-01-31) — Investments And Advances: 0.00
IMMR cash_flow (quarterly, 2026-01-31) — Issuance Of Debt: 254800000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Long Term Capital Lease Obligation: 132389000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Long Term Debt: 138400000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 270789000.00
IMMR cash_flow (quarterly, 2026-01-31) — Long Term Debt Issuance: 254800000.00
IMMR cash_flow (quarterly, 2026-01-31) — Long Term Debt Payments: -238900000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Minority Interest: 266619000.00
IMMR income_statement (quarterly, 2026-01-31) — Minority Interests: -133000.00
IMMR cash_flow (quarterly, 2026-01-31) — Net Business Purchase And Sale: 0.00
IMMR balance_sheet (quarterly, 2026-01-31) — Net Debt: 8573000.00
IMMR income_statement (quarterly, 2026-01-31) — Net Income: -10266000.00
IMMR income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: -10266000.00
IMMR income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: -10133000.00
IMMR income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: -10266000.00
IMMR income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: -10266000.00
IMMR cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: -10133000.00
IMMR income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: -10133000.00
IMMR income_statement (quarterly, 2026-01-31) — Net Interest Income: -8403000.00
IMMR cash_flow (quarterly, 2026-01-31) — Net Investment Purchase And Sale: 13723000.00
IMMR cash_flow (quarterly, 2026-01-31) — Net Issuance Payments Of Debt: 15900000.00
IMMR cash_flow (quarterly, 2026-01-31) — Net Long Term Debt Issuance: 15900000.00
IMMR income_statement (quarterly, 2026-01-31) — Net Non Operating Interest Income Expense: -8403000.00
IMMR cash_flow (quarterly, 2026-01-31) — Net Other Financing Charges: -3128000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Net PPE: 228882000.00
IMMR cash_flow (quarterly, 2026-01-31) — Net PPE Purchase And Sale: -3730000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: 137526000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Assets: 1418000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Liabilities: 19121000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Revenue: 6444000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Taxes Assets: 1418000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Taxes Liabilities: 12677000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Non Current Prepaid Assets: 201000.00
IMMR income_statement (quarterly, 2026-01-31) — Normalized EBITDA: 16704000.00
IMMR income_statement (quarterly, 2026-01-31) — Normalized Income: -9655200.00
IMMR cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: -33762000.00
IMMR cash_flow (quarterly, 2026-01-31) — Operating Gains Losses: 6067000.00
IMMR income_statement (quarterly, 2026-01-31) — Operating Income: 7102000.00
IMMR income_statement (quarterly, 2026-01-31) — Operating Revenue: 518488000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 33055059.00
IMMR balance_sheet (quarterly, 2026-01-31) — Other Current Assets: 43618000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Other Current Liabilities: 11537000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Other Equity Adjustments: 122000.00
IMMR income_statement (quarterly, 2026-01-31) — Other Income Expense: -2117000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Other Intangible Assets: 88695000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Other Inventories: 43662000.00
IMMR cash_flow (quarterly, 2026-01-31) — Other Non Cash Items: 32000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Other Non Current Assets: 30981000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Other Non Current Liabilities: 26834000.00
IMMR income_statement (quarterly, 2026-01-31) — Other Non Operating Income Expenses: -1099000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Other Properties: 228882000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Other Short Term Investments: 48094000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Payables: 319280000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 446137000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 457000.00
IMMR income_statement (quarterly, 2026-01-31) — Pretax Income: -3418000.00
IMMR cash_flow (quarterly, 2026-01-31) — Purchase Of Business: 0.00
IMMR cash_flow (quarterly, 2026-01-31) — Purchase Of Investment: -5085000.00
IMMR cash_flow (quarterly, 2026-01-31) — Purchase Of PPE: -3730000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Receivables: 418755000.00
IMMR income_statement (quarterly, 2026-01-31) — Reconciled Cost Of Revenue: 425554000.00
IMMR income_statement (quarterly, 2026-01-31) — Reconciled Depreciation: 10701000.00
IMMR income_statement (quarterly, 2026-01-31) — Rent Expense Supplemental: 24212000.00
IMMR cash_flow (quarterly, 2026-01-31) — Repayment Of Debt: -238900000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Retained Earnings: 29961000.00
IMMR cash_flow (quarterly, 2026-01-31) — Sale Of Investment: 18808000.00
IMMR cash_flow (quarterly, 2026-01-31) — Sale Of PPE: 0.00
IMMR income_statement (quarterly, 2026-01-31) — Selling General And Administration: 75131000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Share Issued: 50274555.00
IMMR income_statement (quarterly, 2026-01-31) — Special Income Charges: -1018000.00
IMMR cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 2017000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 295383000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: 137526000.00
IMMR income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: -407200.00
IMMR income_statement (quarterly, 2026-01-31) — Tax Provision: 6715000.00
IMMR income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.40
IMMR balance_sheet (quarterly, 2026-01-31) — Total Assets: 1432720000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 433783000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Total Debt: 310770000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 562002000.00
IMMR income_statement (quarterly, 2026-01-31) — Total Expenses: 511386000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 870718000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 419339000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 316744000.00
IMMR income_statement (quarterly, 2026-01-31) — Total Operating Income As Reported: 4985000.00
IMMR income_statement (quarterly, 2026-01-31) — Total Unusual Items: -1018000.00
IMMR income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: -1018000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Treasury Shares Number: 17219496.00
IMMR balance_sheet (quarterly, 2026-01-31) — Treasury Stock: 113651000.00
IMMR balance_sheet (quarterly, 2026-01-31) — Working Capital: 459407000.00
IMMX income_statement (annual, 2021-12-31) — Basic Average Shares: 3672611.00
IMMX income_statement (annual, 2021-12-31) — Basic EPS: -6.64
IMMX cash_flow (annual, 2021-12-31) — Capital Expenditure: -802.00
IMMX balance_sheet (annual, 2021-12-31) — Cash Financial: 17644478.00
IMMX cash_flow (annual, 2021-12-31) — Change In Accrued Expense: 120154.00
IMMX cash_flow (annual, 2021-12-31) — Change In Interest Payable: 120154.00
IMMX cash_flow (annual, 2021-12-31) — Common Stock Payments: 0.00
IMMX balance_sheet (annual, 2021-12-31) — Current Debt: 50000.00
IMMX balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 50000.00
IMMX balance_sheet (annual, 2021-12-31) — Current Notes Payable: 50000.00
IMMX income_statement (annual, 2021-12-31) — Diluted Average Shares: 3672611.00
IMMX income_statement (annual, 2021-12-31) — Diluted EPS: -6.64
IMMX cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: 22759829.00
IMMX income_statement (annual, 2021-12-31) — Gain On Sale Of Security: -22759829.00
IMMX income_statement (annual, 2021-12-31) — Interest Expense: 179853.00
IMMX income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 179853.00
IMMX balance_sheet (annual, 2021-12-31) — Interest Payable: 9099.00
IMMX cash_flow (annual, 2021-12-31) — Issuance Of Debt: 200000.00
IMMX cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 200000.00
IMMX cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 200000.00
IMMX cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 200000.00
IMMX cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 200000.00
IMMX cash_flow (annual, 2021-12-31) — Operating Gains Losses: 22845999.00
IMMX income_statement (annual, 2021-12-31) — Other Income Expense: -22845999.00
IMMX cash_flow (annual, 2021-12-31) — Other Non Cash Items: 118157.00
IMMX income_statement (annual, 2021-12-31) — Other Special Charges: 86170.00
IMMX balance_sheet (annual, 2021-12-31) — Preferred Stock: 0.00
IMMX cash_flow (annual, 2021-12-31) — Repayment Of Debt: 0.00
IMMX cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: 0.00
IMMX cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 200000.00
IMMX cash_flow (annual, 2021-12-31) — Short Term Debt Payments: 0.00
IMMX income_statement (annual, 2021-12-31) — Special Income Charges: -86170.00
IMMX balance_sheet (annual, 2021-12-31) — Total Debt: 50000.00
IMMX income_statement (annual, 2021-12-31) — Total Unusual Items: -22845999.00
IMMX income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: -22845999.00
IMMX income_statement (annual, 2022-12-31) — +Operating Expense: 8218948.00
IMMX income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
IMMX balance_sheet (annual, 2022-12-31) — Accounts Payable: 143074.00
IMMX balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 51156597.00
IMMX income_statement (annual, 2022-12-31) — Basic Average Shares: 13887309.00
IMMX income_statement (annual, 2022-12-31) — Basic EPS: -0.59
IMMX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 17644478.00
IMMX balance_sheet (annual, 2022-12-31) — Capital Stock: 1397.00
IMMX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 13436714.00
IMMX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 13436714.00
IMMX balance_sheet (annual, 2022-12-31) — Cash Financial: 13436714.00
IMMX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 3232063.00
IMMX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 0.00
IMMX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -7408303.00
IMMX cash_flow (annual, 2022-12-31) — Change In Account Payable: 1131736.00
IMMX cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -9099.00
IMMX cash_flow (annual, 2022-12-31) — Change In Interest Payable: -9099.00
IMMX cash_flow (annual, 2022-12-31) — Change In Payable: 1131736.00
IMMX cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1122637.00
IMMX cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -691047.00
IMMX cash_flow (annual, 2022-12-31) — Change In Receivables: -236384.00
IMMX cash_flow (annual, 2022-12-31) — Change In Working Capital: 195206.00
IMMX cash_flow (annual, 2022-12-31) — Changes In Cash: -4176240.00
IMMX balance_sheet (annual, 2022-12-31) — Common Stock: 1397.00
IMMX balance_sheet (annual, 2022-12-31) — Common Stock Equity: 13159805.00
IMMX cash_flow (annual, 2022-12-31) — Common Stock Issuance: 3388750.00
IMMX cash_flow (annual, 2022-12-31) — Common Stock Payments: -99963.00
IMMX balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 1130222.00
IMMX balance_sheet (annual, 2022-12-31) — Current Assets: 14897817.00
IMMX balance_sheet (annual, 2022-12-31) — Current Liabilities: 1273296.00
IMMX balance_sheet (annual, 2022-12-31) — Current Notes Payable: 0.00
IMMX cash_flow (annual, 2022-12-31) — Depreciation: 2135.00
IMMX cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 2135.00
IMMX cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 2135.00
IMMX income_statement (annual, 2022-12-31) — Diluted Average Shares: 13887309.00
IMMX income_statement (annual, 2022-12-31) — Diluted EPS: -0.59
IMMX income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -8229713.00
IMMX income_statement (annual, 2022-12-31) — EBIT: -8218948.00
IMMX income_statement (annual, 2022-12-31) — EBITDA: -8216813.00
IMMX cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -31524.00
IMMX cash_flow (annual, 2022-12-31) — End Cash Position: 13436714.00
IMMX cash_flow (annual, 2022-12-31) — Financing Cash Flow: 3232063.00
IMMX cash_flow (annual, 2022-12-31) — Free Cash Flow: -7408303.00
IMMX balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 87021.00
IMMX income_statement (annual, 2022-12-31) — General And Administrative Expense: 4023170.00
IMMX balance_sheet (annual, 2022-12-31) — Gross PPE: 3560.00
IMMX cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 0.00
IMMX income_statement (annual, 2022-12-31) — Interest Expense: 497.00
IMMX income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 497.00
IMMX income_statement (annual, 2022-12-31) — Interest Income: 0.00
IMMX income_statement (annual, 2022-12-31) — Interest Income Non Operating: 0.00
IMMX cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 9596.00
IMMX balance_sheet (annual, 2022-12-31) — Interest Payable: 0.00
IMMX balance_sheet (annual, 2022-12-31) — Invested Capital: 13159805.00
IMMX cash_flow (annual, 2022-12-31) — Investing Cash Flow: 0.00
IMMX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 3388750.00
IMMX cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
IMMX balance_sheet (annual, 2022-12-31) — Long Term Provisions: 475000.00
IMMX balance_sheet (annual, 2022-12-31) — Minority Interest: 0.00
IMMX income_statement (annual, 2022-12-31) — Minority Interests: 0.00
IMMX cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 3288787.00
IMMX income_statement (annual, 2022-12-31) — Net Income: -8229713.00
IMMX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -8229713.00
IMMX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -8229713.00
IMMX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -8229713.00
IMMX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -8229713.00
IMMX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -8229713.00
IMMX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -8229713.00
IMMX income_statement (annual, 2022-12-31) — Net Interest Income: -497.00
IMMX cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -50000.00
IMMX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -497.00
IMMX cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -6724.00
IMMX balance_sheet (annual, 2022-12-31) — Net PPE: 3560.00
IMMX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 0.00
IMMX cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -50000.00
IMMX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 13159805.00
IMMX balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 6724.00
IMMX income_statement (annual, 2022-12-31) — Normalized EBITDA: -8216813.00
IMMX income_statement (annual, 2022-12-31) — Normalized Income: -8229713.00
IMMX cash_flow (annual, 2022-12-31) — Operating Cash Flow: -7408303.00
IMMX income_statement (annual, 2022-12-31) — Operating Income: -8218948.00
IMMX income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
IMMX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 13892122.00
IMMX balance_sheet (annual, 2022-12-31) — Other Current Assets: 78067.00
IMMX balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 87021.00
IMMX income_statement (annual, 2022-12-31) — Other Gand A: 4023170.00
IMMX cash_flow (annual, 2022-12-31) — Other Non Cash Items: 100000.00
IMMX balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 6724.00
IMMX balance_sheet (annual, 2022-12-31) — Other Properties: 3560.00
IMMX balance_sheet (annual, 2022-12-31) — Payables: 143074.00
IMMX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1273296.00
IMMX balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
IMMX balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1127331.00
IMMX income_statement (annual, 2022-12-31) — Pretax Income: -8219445.00
IMMX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
IMMX cash_flow (annual, 2022-12-31) — Purchase Of PPE: 0.00
IMMX balance_sheet (annual, 2022-12-31) — Receivables: 255705.00
IMMX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 2135.00
IMMX cash_flow (annual, 2022-12-31) — Repayment Of Debt: -50000.00
IMMX cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -99963.00
IMMX income_statement (annual, 2022-12-31) — Research And Development: 4195778.00
IMMX balance_sheet (annual, 2022-12-31) — Retained Earnings: -37985247.00
IMMX income_statement (annual, 2022-12-31) — Selling General And Administration: 4023170.00
IMMX balance_sheet (annual, 2022-12-31) — Share Issued: 13964485.00
IMMX cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 0.00
IMMX cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -50000.00
IMMX income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
IMMX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 624069.00
IMMX balance_sheet (annual, 2022-12-31) — Stockholders Equity: 13159805.00
IMMX balance_sheet (annual, 2022-12-31) — Tangible Book Value: 13159805.00
IMMX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
IMMX income_statement (annual, 2022-12-31) — Tax Provision: 10268.00
IMMX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
IMMX balance_sheet (annual, 2022-12-31) — Taxes Receivable: 255705.00
IMMX balance_sheet (annual, 2022-12-31) — Total Assets: 14908101.00
IMMX balance_sheet (annual, 2022-12-31) — Total Capitalization: 13159805.00
IMMX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 13159805.00
IMMX income_statement (annual, 2022-12-31) — Total Expenses: 8218948.00
IMMX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1748296.00
IMMX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 10284.00
IMMX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 475000.00
IMMX income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -8218948.00
IMMX income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
IMMX income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
IMMX balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 72363.00
IMMX balance_sheet (annual, 2022-12-31) — Treasury Stock: 99963.00
IMMX balance_sheet (annual, 2022-12-31) — Working Capital: 13624521.00
IMMX income_statement (annual, 2023-12-31) — +Operating Expense: 16141113.00
IMMX income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
IMMX balance_sheet (annual, 2023-12-31) — Accounts Payable: 1433022.00
IMMX balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -14314.00
IMMX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 69779706.00
IMMX income_statement (annual, 2023-12-31) — Basic Average Shares: 17341146.00
IMMX income_statement (annual, 2023-12-31) — Basic EPS: -0.89
IMMX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 13436714.00
IMMX balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 0.00
IMMX cash_flow (annual, 2023-12-31) — Capital Expenditure: -52089.00
IMMX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 0.00
IMMX balance_sheet (annual, 2023-12-31) — Capital Stock: 2000.00
IMMX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 17509791.00
IMMX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 17509791.00
IMMX balance_sheet (annual, 2023-12-31) — Cash Financial: 17509791.00
IMMX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 15463512.00
IMMX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -52089.00
IMMX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -11371438.00
IMMX cash_flow (annual, 2023-12-31) — Change In Account Payable: 2434467.00
IMMX cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 0.00
IMMX cash_flow (annual, 2023-12-31) — Change In Interest Payable: 0.00
IMMX cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 0.00
IMMX cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 0.00
IMMX cash_flow (annual, 2023-12-31) — Change In Payable: 2434467.00
IMMX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 2434467.00
IMMX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 111842.00
IMMX cash_flow (annual, 2023-12-31) — Change In Receivables: -893401.00
IMMX cash_flow (annual, 2023-12-31) — Change In Working Capital: 1652908.00
IMMX cash_flow (annual, 2023-12-31) — Changes In Cash: 4039985.00
IMMX balance_sheet (annual, 2023-12-31) — Common Stock: 2000.00
IMMX balance_sheet (annual, 2023-12-31) — Common Stock Equity: 16405114.00
IMMX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 15695510.00
IMMX cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
IMMX balance_sheet (annual, 2023-12-31) — Construction In Progress: 0.00
IMMX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1710907.00
IMMX balance_sheet (annual, 2023-12-31) — Current Assets: 19787750.00
IMMX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 0.00
IMMX balance_sheet (annual, 2023-12-31) — Current Liabilities: 3721783.00
IMMX cash_flow (annual, 2023-12-31) — Depreciation: 5468.00
IMMX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 5468.00
IMMX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 5468.00